Company Filing History:
2 out of 8,373 
1 out of 164 
1 out of 818 
Years Active: 2024
Title: The Innovative Mind of Becky Leifer
Introduction
Becky Leifer, an accomplished inventor based in Malden, MA, has made significant contributions to the field of pharmaceutical sciences through her innovative inventions. With a remarkable portfolio that includes two patents, she stands out in the realm of research and development.
Latest Patents
Becky Leifer's latest patents reflect her focus on combatting serious health conditions through targeted molecular therapies. Her first patent involves small molecule inhibitors of Interleukin-4, which targets IL-4 and/or IL-13 inhibitors and their therapeutic applications. The second patent showcases her work on small molecule binders of the oncogenic fusion transcription factor PAX3-FOXO1. This invention details compounds characterized by a specific formula involving a FOXO1 fusion protein binding moiety, a bivalent linker, and an ubiquitin ligase binding moiety. These compounds are not only innovative but also have significant potential in the development of effective pharmaceutical compositions.
Career Highlights
Throughout her career, Becky has collaborated with leading institutions that have played a pivotal role in her research endeavors. She has been associated with the Massachusetts Institute of Technology, a prestigious institution known for its cutting-edge research, and the Universität Zürich, where she furthered her scientific pursuits. Her innovative work and dedication to her field have established her as a notable figure among inventors.
Collaborations
Becky has worked closely with Shelby Doyle, another talented woman in the field, indicating a strong collaborative spirit in her career. This partnership has contributed to the advancement of their respective research projects, underscoring the importance of teamwork in innovation.
Conclusion
Becky Leifer’s work exemplifies the impact that innovative thinking can have on addressing complex health challenges. With her two patents and the continued collaboration with esteemed institutions and colleagues, she remains a vital contributor to the landscape of pharmaceutical research and development. Her contributions not only signify progress in scientific discovery but also inspire future generations of inventors.